FERLAZZO, Guido
 Distribuzione geografica
Continente #
EU - Europa 8.185
NA - Nord America 7.081
AS - Asia 3.985
SA - Sud America 1.280
Continente sconosciuto - Info sul continente non disponibili 322
AF - Africa 109
OC - Oceania 7
Totale 20.969
Nazione #
US - Stati Uniti d'America 6.909
RU - Federazione Russa 4.186
SG - Singapore 1.615
CN - Cina 1.247
BR - Brasile 1.114
IE - Irlanda 854
SE - Svezia 764
IT - Italia 701
HK - Hong Kong 436
DE - Germania 318
UA - Ucraina 300
PL - Polonia 265
FR - Francia 242
VN - Vietnam 222
FI - Finlandia 153
GB - Regno Unito 151
IN - India 108
CA - Canada 67
AR - Argentina 58
MX - Messico 54
BD - Bangladesh 49
BE - Belgio 45
TR - Turchia 42
AT - Austria 41
ZA - Sudafrica 41
CZ - Repubblica Ceca 34
NL - Olanda 34
JP - Giappone 32
IQ - Iraq 31
ID - Indonesia 29
EC - Ecuador 26
ES - Italia 26
MA - Marocco 21
CO - Colombia 19
PK - Pakistan 19
UZ - Uzbekistan 19
SA - Arabia Saudita 17
PY - Paraguay 16
VE - Venezuela 16
CL - Cile 12
TN - Tunisia 12
JM - Giamaica 11
KR - Corea 11
MY - Malesia 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
PH - Filippine 10
CR - Costa Rica 9
IR - Iran 9
KZ - Kazakistan 9
NP - Nepal 9
AZ - Azerbaigian 8
KE - Kenya 8
BO - Bolivia 7
EG - Egitto 7
IL - Israele 7
AL - Albania 6
RO - Romania 6
RS - Serbia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
EE - Estonia 5
GR - Grecia 5
NI - Nicaragua 5
PE - Perù 5
AU - Australia 4
BY - Bielorussia 4
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
JO - Giordania 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
SV - El Salvador 4
TH - Thailandia 4
AM - Armenia 3
CI - Costa d'Avorio 3
HU - Ungheria 3
KH - Cambogia 3
LB - Libano 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
Totale 20.628
Città #
Moscow 1.178
Ashburn 1.158
Singapore 922
Dublin 858
Chandler 684
Dallas 669
Jacksonville 551
Nyköping 500
Hong Kong 435
Beijing 412
Messina 341
San Jose 340
Warsaw 253
The Dalles 229
Council Bluffs 223
Los Angeles 173
Princeton 150
Ann Arbor 147
Lauterbourg 138
Medford 138
Cambridge 117
Des Moines 110
Boardman 105
New York 101
São Paulo 83
Buffalo 80
Munich 71
Dearborn 66
Jinan 64
Ho Chi Minh City 61
Santa Clara 58
Tianjin 54
Guangzhou 49
Hanoi 46
Frankfurt am Main 44
Redondo Beach 44
Brussels 43
Shenyang 42
Rio de Janeiro 38
Woodbridge 38
Belo Horizonte 35
Wilmington 34
Seattle 33
Vienna 33
Brno 31
Tokyo 29
Nanjing 28
Orem 28
Stockholm 27
Brooklyn 26
Chennai 26
Hebei 26
Johannesburg 26
Milan 26
Catania 25
Zhengzhou 25
Phoenix 24
San Mateo 24
Shanghai 24
Rome 23
Chicago 22
Haikou 22
Houston 22
Montreal 21
Changsha 20
Dong Ket 20
Lancaster 20
Taizhou 20
Turku 20
Amsterdam 19
Tashkent 19
London 18
Atlanta 17
Ningbo 17
Sorocaba 17
Denver 16
Düsseldorf 16
Jakarta 16
San Francisco 16
Brasília 15
Curitiba 15
Hyderabad 15
Nanchang 15
Saint Petersburg 15
Toronto 15
Boston 14
Campinas 14
Hangzhou 14
Helsinki 14
Nuremberg 14
Porto Alegre 14
Pune 14
Shenzhen 14
Ribeirão Preto 13
Mumbai 12
Caxias do Sul 11
Columbus 11
Fuzhou 11
Genoa 11
Manchester 11
Totale 12.006
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 259
A multivariate analysis of Multiple Myeloma subtype plasma cells 251
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 248
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 217
Divergent signaling pathways regulate IL-12 production induced by different species of Lactobacilli in human dendritic cells 210
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 209
Acquisition and presentation of tumor antigens by dendritic cells. 203
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 200
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 197
Oxidative stress induces Wnt canonical/non-canonical pathways modulation in colon cancer cell models 196
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. 194
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 193
Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise 191
Biological parameters in breast cancer 190
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 186
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 186
Cross-dressing: an alternative mechanism for antigen presentation 183
Intralesional sonographically guided injections of lymphokine- activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: A pilot study 182
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 181
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 180
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 180
Natural killer cells in the innate immunity network of atherosclerosis. 180
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 178
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 178
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 177
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 177
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 177
CLASS-I HLA AND ICAM-1 MOLECULE EXPRESSION IN PRIMARY CULTURED CANCER-CELLS DECREASES IN A STATIONARY-PHASE OF CELL-GROWTH 176
METALLIC MICROSPHERE CONJUGATED MONOCLONAL-ANTIBODIES SPECIFIC FOR A CELL-SURFACE DETERMINANT ENHANCE DAMAGE TO CANCER-CELLS EXPOSED TO SHOCK-WAVES 174
Biological parameters in breast cancer. 173
Detection Of Lynphocytic β - Endorphin In Cancer Patients During Hospedalization And After In Vitro Culture With IL 2. 173
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 171
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 171
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 168
Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study. 168
FCM detection of lymphocytic beta-endorphin in cancer patients during hospitalization and after in vitro culture with IL2 167
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 167
SPONTANEOUS TRANSFORMATION AND IMMORTALIZATION OF PERITONEAL- MACROPHAGES OF HUMAN-ORIGIN 167
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients 167
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 166
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 165
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 165
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 164
ILC in chronic inflammation, cancer and targeting with biologicals 162
T cell polarizing properties of probiotic bacteria 161
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 159
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 158
Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies 157
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 157
Evaluation of the canonical/non-canonical Wnt signalling pathways during oxidative stress in colorectal cancer cell line models 153
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells 152
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 152
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 151
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2 151
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 151
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 151
The Yin and Yang of Innate Lymphoid Cells in Cancer 150
Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells 149
Adaptative immunotherapy of advanced solid tumors 149
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 147
Adoptive immunotherapy of advanced solid tumors: An eight year clinical experience 147
Phytochemicals, Antioxidant and Antiproliferative Properties of Rosmarinus officinalis L on U937 and CaCo-2 Cells 147
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 145
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review 144
Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells 143
Human NK cells and NK receptors. 143
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 141
Effect of oxidative stress on canonical/non-canonical WNT pathways in colon cancer cell lines 141
Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. 140
In vitro modulation of lymphocytes ß-endorphin (ß-END) studied by flow cytometry. 140
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 139
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 138
Characterization of human afferent lymph dendritic cells from seroma fluids. 138
EMODERIVATO IN FORMA DI GEL COMPRENDENTE FIBRINA, PIASTRINE E LEUCOCITI 137
Detection of MAGE-1, -2 and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 136
Mucosal Immunology and Probiotics. 136
null 135
Vitamin D and inflammatory bowel disease 135
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 135
Flavonoid profile, antioxidant and cytotoxic activity of different extracts from Algerian Rhamnus alaternus L. bark 131
Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death 130
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients. 129
Th17 skewing in the GALT of a Crohn disease patient upon Lactobacillus rhamnosus GG consumption 128
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. 126
Cognate HLA absence in trans diminishes human NK cell education 126
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 126
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses 124
Phage-phenotype imaging of myeloma plasma cells by phage display 124
BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features 123
On immunostimulants and dendritic cell activation 123
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 122
MORPHOLOGICAL, PHENOTYPIC AND KARYOTYPIC CHARACTERIZATION OF A NOVEL NATURAL-KILLER-CELL TARGET - EVIDENCE OF INVOLVEMENT OF MHC CLASS-I MOLECULES IN NK CELL RECOGNITION 121
Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells. 121
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 119
Expansion of natural killer cells in patients with head and neck cancer: Detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells 118
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 116
Identification of Natural Killer Cells in Tissues and Their Isolation 116
Novel perspectives on dendritic cell-based immunotherapy of cancer. 110
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 110
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 109
Totale 15.827
Categoria #
all - tutte 70.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022926 0 157 17 31 46 16 74 52 14 64 130 325
2022/20232.633 232 261 119 217 195 260 37 163 1.030 10 63 46
2023/2024664 63 106 82 39 55 117 22 28 8 31 5 108
2024/20253.252 66 40 58 196 155 118 74 754 771 216 280 524
2025/20269.997 506 619 669 692 866 2.067 1.198 1.315 1.255 445 178 187
2026/2027433 163 270 0 0 0 0 0 0 0 0 0 0
Totale 20.969